Topics

All Topics

On the Road

Major Medical

Avandia Recall Information

Chrissie Cole

Contributor

Posted by Chrissie ColeMay 28, 2007 11:45 PM

Tags: Defective Drugs

0 Comments

Print Article

The Food and Drug Administration (FDA) is aware of a safety issue regarding the drug rosiglitazone maleate, marketed under the brand name Avandia. The drug is for type 2 diabetes.

Safety data analysis of controlled clinical trials shows a significant increase in the risk of heart attack and heart related health issues and deaths in patients that take Avandia.

Published and unpublished data from long term clinical trials provides a contradictory argument about the risk of heart related health problems in patients taking Avandia.

The FDA's review of data is still ongoing. The FDA is yet to confirm the significance of the reported increase risk of heart risks in context to other such studies.

0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard Las Vegas

Keep up with the latest updates using your favorite RSS reader

Legal Assistance Center

More Info

First Name

Last Name

Phone

Zip

Better Business Bureau Accredited Business

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.